Skip to main content

Advertisement

SpringerLink
Log in

Health-related quality of life and well-being in adults with idiopathic inflammatory myopathy

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Health-related quality of life (HRQoL) and well-being are concepts that attempt to objectively capture a person’s subjective perceptions of vitality and energy. Our objectives were to determine HRQoL and well-being in adult patients diagnosed with inflammatory myopathy who attended at our outpatient clinic and to investigate clinical and biological correlations with these concepts. Sixty-two patients (52 women), with a mean age of 50.7 years, were evaluated in this cross-sectional study—47 with dermatomyositis and 15 with polymyositis. Disease damage and activity were assessed with the International Myositis Assessment and Clinical Studies-validated instruments. Manual muscle testing was used to evaluate muscle strength. Quality of life was evaluated with the WHO instrument (WHO Quality of Life Measure (WHOQOL-BREF)), adapted for use in the Spanish population, and well-being with the WHO-Five Well-Being Index (WHO-5). t tests were conducted to examine differences in HRQoL and well-being outcomes in relation to several disease- and patient-related variables. Correlation analyses were performed with the Pearson correlation coefficient. None of the clinical or biological variables analyzed was significantly associated with a poorer HRQoL or well-being. No differences in HRQoL or WHO-5 well-being score were found between the two myositis subgroups (dermatomyositis vs. polymyositis). Disease activity and muscle weakness were negatively associated with the physical and environmental domains of the HRQoL, respectively (p < 0.002), but not with well-being. Disease duration did not have a significant impact on HRQoL or well-being. In adult patients with myositis, disease activity and muscle weakness are associated with poorer HRQoL in the physical health and environmental domains, respectively.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

ELISA:

Enzyme-linked immunosorbent assay

HRQoL:

Health-related quality of life

IMACS:

International Myositis Assessment and Clinical Studies

MDI:

Myositis Damage Index

MITAX:

Myositis Intention-to-Treat Activity Index

MMT8:

Manual muscle testing

MYOACT:

Myositis Disease Activity Assessment Visual Analog Scales

References

  1. Dalakas MC, Hohlfeld R (2003) Polymyositis and dermatomyositis. Lancet 362:971–982

    Article  CAS  PubMed  Google Scholar 

  2. Bronner IM, van der Meulen MFG, de Visser M, Kalmijn S, van Venrooij WJ, Voskuyl AE et al (2006) Long-term outcome in polymyositis and dermatomyositis. Ann Rheum Dis 65:1456–1461

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Hundley JL, Carroll CL, Lang W, Snively B, Feldman SR, Jorizzo JL (2006) Cutaneous symptoms of dermatomyositis significantly impact patients’ quality of life. J Am Acad Dermatol 54:217–220

    Article  PubMed  Google Scholar 

  4. Drouet B, Le Loët X, Vittecoq O, Nouvet G, Genevois A, Lauret P et al (1996) A study of long-term survival, functional outcome and quality of life in patients with polymyositis or dermatomyositis. Rev Rhum Engl Educ 63:321–330

    CAS  Google Scholar 

  5. Rider LG, Werth VP, Huber AM, Alexanderson H, Rao AP, Ruperto N, Herbelin L, Barohn R, Isenberg D, Miller FW (2011) Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI). Arthritis Care Res (Hoboken) 63(Suppl 11):S118–S157

    Article  Google Scholar 

  6. Chung YL, Mitchell HL, Houssien DA, Al-Mahrouki H, Carr AJ, Scott DL (2001) A comparative study of outcome in myositis and other musculoskeletal disorders assessed using the Nottingham health profile. Clin Exp Rheumatol 19:447–450

    CAS  PubMed  Google Scholar 

  7. Alexanderson H, Lundberg IE (2007) Disease-specific quality indicators, outcome measures and guidelines in polymyositis and dermatomyositis. Clin Exp Rheumatol 25(suppl 47):S153–S158

    Google Scholar 

  8. Carroll CL, Lang W, Snively B, Feldman SR, Callen J, Jorizzo JL (2008) Development and validation of the Dermatomyositis Skin Severity Index. Br J Dermatol 158:345–350

    Article  CAS  PubMed  Google Scholar 

  9. Regardt M, Henriksson EW, Alexanderson H, Lundberg IE (2011) Patients with polymyositis or dermatomyositis have reduced grip force and health-related quality of life in comparison with reference values: an observational study. Rheumatology (Oxford) 50:578–585

    Article  Google Scholar 

  10. Development of the World Health Organization WHOQOL-BREF quality of life assessment (1988) The WHOQOL Group. Psychol Med 28:551–558

    Google Scholar 

  11. Skevington SM, Lotfy M, O’Connell KA, WHOQOL Group (2004) The World Health Organisation’s WHOQOL-BREF quality of life assessment: psychometric properties and the results of the international field trial. A report from the WHOQOL Group. Qual Life Res 13:299–310

    Article  CAS  PubMed  Google Scholar 

  12. Asnani MR, Lipps GA, Reid ME (2009) Utility of WHOQOL-BREF in measuring quality of life in sickle cell disease. Health and Qual Life Outcome 7:75

    Article  Google Scholar 

  13. Taylor WJ, Myers J, Simpson RT, Mcpherson KM, Weatherall M (2004) Quality of life of people with rheumatoid arthritis as measured by the World Health Organization Quality of Life Instrument, Short Form (WHOQOL-BREF): score distributions and psychometric properties. Arthritis Rheum 51:350–357

    Article  PubMed  Google Scholar 

  14. Bech P, Hamilton M (2012) Appendix 1: The clinical validity of rating scales for depression Copenhagen, in Clinical Psychometrics, John Wiley & Sons, Ltd, Chichester, West Sussex, UK. doi:10.1002/9781118511800.app1

  15. Bech P, Olsen LR, Kjoller M, Rasmussen NK (2003) Measuring well-being rather than the absence of distress symptoms: a comparison of the SF-36 Mental Health subscale and the WHO-Five Well-Being Scale. Int J Methods Psychiatr Res 12:85–91

    Article  PubMed  Google Scholar 

  16. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344–347

    Article  CAS  PubMed  Google Scholar 

  17. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292:403–407

    Article  CAS  PubMed  Google Scholar 

  18. Selva-O'Callaghan A, Labrador-Horrillo M, Solans-Laque R, Simeon-Aznar CP, Martínez-Gómez X, Vilardell-Tarrés M (2006) Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy. Arthritis Rheum 55:791–798

    Article  PubMed  Google Scholar 

  19. International Myositis Assessment and Clinical Studies (IMACS) Group website. https://dirapps.niehs.nih.gov/imacs/. Accessed 24 May 2014

  20. Isenberg DA, Allen E, Farewell V, Ehrenstein MR, Hanna MG, Lundberg IE et al (2004) International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology (Oxford) 43:49–54

    Article  CAS  Google Scholar 

  21. Harris-Love MO, Shrader JA, Koziol D, Pahlajani N, Jain M, Cintas HL et al (2009) Distribution and severity of weakness among patients with polymyositis, dermatomyositis and juvenile dermatomyositis. Rheumatology (Oxford) 48:134–139

    Article  CAS  Google Scholar 

  22. Rider LG, Koziol D, Giannini EH, Jain MS, Smith MR, Whitney-Mahoney K et al (2010) Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies. Arthritis Care Res (Hoboken) 62:465–472

    Article  Google Scholar 

  23. Lucas-Carrasco R (2012) The WHO, quality of life (WHOQOL) questionnaire: Spanish development and validation studies. Qual Life Res 21:161–165

    Article  PubMed  Google Scholar 

  24. Lucas-Carrasco R (2012) Reliability and validity of the Spanish version of the World Health Organization-Five Well-Being Index in elderly. Psychiatry Clin Neurosci 66:508–513

    Article  PubMed  Google Scholar 

  25. Cohen J (1988) Statistical power analysis for behavioral sciences, 2nd edn. Lawrence Erlbaum Associates, Hilldale

    Google Scholar 

  26. Sultan SM, Ioannou Y, Moss K, Isenberg DA (2002) Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality. Rheumatology 41:22

    Article  CAS  PubMed  Google Scholar 

  27. Ponyi A, Borgulya G, Constantin T, Váncss A, Gergely L, Dankó K (2005) Functional outcome and quality of life in adult patients with idiopathic inflammatory myositis. Rheumatology 44:83–88

    Article  CAS  PubMed  Google Scholar 

  28. Burns TM, Graham CD, Rose MR, Simmons Z (2012) Quality of life and measures of quality of life in patients with neuromuscular disorders. Muscle Nerve 46:9–25

    Article  PubMed  Google Scholar 

  29. Graham CD, Rose MR, Grunfeld EA, Kyle SD, Weinman J (2011) A systematic review of quality of life in adults with muscle disease. J Neurol 258:1581–1592

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We are grateful to Dr. Lisa Rider and Dr. Frederick W. Miller for their critical review of the manuscript and valuable suggestions. This study was funded in part by a grant (FIS/2012 PI12--01320) from the Spanish Ministry of Health and Consumer Affairs.

Disclosures

None.

Author information

Authors and Affiliations

  1. Department of Social Psychology, PsicoSAO-Research Group in Social, Environmental, and Organizational Psychology (2009 SRG; Comissionat per a Universitats i Recerca, DIUE from the Generalitat de Catalunya), Universitat de Barcelona, Barcelona, Spain

    Imma Armadans-Tremolosa & Bienvenido Visauta-Vinacua

  2. Department of Behavioral Sciences Methods, Universitat de Barcelona, Barcelona, Spain

    Georgina Guilera

  3. Internal Medicine Department, Vall d’Hebron General Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain

    Albert Selva-O’Callaghan, Iago Pinal-Fernández & Miquel Vilardell-Tarrés

  4. C/ Siracusa Nº 12 Bis “A”, Barcelona, 08012, Spain

    Albert Selva-O’Callaghan

Authors
  1. Imma Armadans-Tremolosa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Albert Selva-O’Callaghan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bienvenido Visauta-Vinacua
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Georgina Guilera
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Iago Pinal-Fernández
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Miquel Vilardell-Tarrés
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Albert Selva-O’Callaghan.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Armadans-Tremolosa, I., Selva-O’Callaghan, A., Visauta-Vinacua, B. et al. Health-related quality of life and well-being in adults with idiopathic inflammatory myopathy. Clin Rheumatol 33, 1119–1125 (2014). https://doi.org/10.1007/s10067-014-2685-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-014-2685-0

Keywords

Search

Navigation